Researchers analyzed data from SELECT, a prostate cancer prevention trial, which enrolled more than 35,000 men from 427 study sites in the U.S., Canada and Puerto Rico. The men were divided into groups and given vitamin E, selenium, both or a placebo.
Here’s what you should know.
1. The team reviewed colonoscopy and sigmoidoscopy reports on 6,546 participants and found that approximately 2,300 had more than one colon polyp during a procedure.
2. The occurrence rate of polyps was the same among all men, regardless of supplement intake.
3. The study backs up previous research that argued that vitamin E and selenium do not prevent prostate cancer.
4. The researchers concluded, “The message to the public is this: Vitamin E and selenium will not prevent colorectal adenomas, which are surrogates for colorectal cancer.”
More articles on gastroenterology/endoscopy:
Olympus, Boston Scientific & more — 3 GI company key notes
GI leader to know: Dr. Eric Osgard of Gastroenterology Consultants
ACG creates new clinical guideline for abnormal liver chemistries: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
